HF10 oncolytic viral therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HF10 oncolytic viral therapy, covering 2019-10-10 to 2019-10-10. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma [Phase 2]